Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.44 USD | +0.33% | +0.47% | -3.47% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 18 | BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 | MT |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 6.96B |
---|---|---|---|---|---|
Net income 2024 * | 272M | Net income 2025 * | 407M | EV / Sales 2024 * | 2.43 x |
Net cash position 2024 * | 939M | Net cash position 2025 * | 1.44B | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
29.3
x | P/E ratio 2025 * |
17.2
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.18% |
Latest transcript on Globus Medical, Inc.
1 day | +0.33% | ||
1 week | +0.47% | ||
Current month | -4.10% | ||
1 month | -1.11% | ||
3 months | -4.72% | ||
6 months | +4.36% | ||
Current year | -3.47% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | +5.19% | ||
0.99% | 152 M€ | -0.54% | - | |
0.74% | 16 M€ | -6.73% | ||
0.44% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 51.44 | +0.33% | 883,839 |
24-04-23 | 51.27 | +0.04% | 900,470 |
24-04-22 | 51.25 | +1.79% | 967,602 |
24-04-19 | 50.35 | -0.79% | 1,059,314 |
24-04-18 | 50.75 | -0.88% | 969,555 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.47% | 6.94B | |
-2.89% | 187B | |
-2.43% | 108B | |
-4.10% | 67.71B | |
+11.10% | 53.07B | |
+15.86% | 47.36B | |
+4.77% | 39.73B | |
+9.55% | 28.56B | |
+1.85% | 26.55B | |
+13.24% | 25.13B |
- Stock Market
- Equities
- GMED Stock